<s id="wsj_0970.1"> 39
1 	 0 	 (S/S)/(S/S) 	 2 	 day One
1 	 2 	 ((S/S)\(S/S))/S[dcl] 	 2 	 day after
4 	 3 	 N/N 	 1 	 Inc. Delmed
4 	 5 	 (S[dcl]\NP)/NP 	 1 	 Inc. made
4 	 10 	 (S[dcl]\NP)/NP 	 1 	 Inc. disclosed <XU>
5 	 2 	 ((S/S)\(S/S))/S[dcl] 	 3 	 made after
8 	 5 	 (S[dcl]\NP)/NP 	 2 	 changes made
8 	 6 	 N/N 	 1 	 changes top
8 	 7 	 N/N 	 1 	 changes management
10 	 2 	 ((S/S)\(S/S))/S[dcl] 	 3 	 disclosed after
12 	 10 	 (S[dcl]\NP)/NP 	 2 	 end disclosed
12 	 11 	 NP[nb]/N 	 1 	 end the
12 	 13 	 (NP\NP)/NP 	 1 	 end of
17 	 13 	 (NP\NP)/NP 	 2 	 tie of
17 	 14 	 NP[nb]/N 	 1 	 tie an
17 	 15 	 N/N 	 1 	 tie important
17 	 16 	 N/N 	 1 	 tie business
20 	 19 	 NP[nb]/N 	 1 	 stock its
20 	 21 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 stock did
20 	 23 	 S[b]\NP 	 1 	 stock trade <XB>
21 	 1 	 S/S 	 1 	 did day
21 	 22 	 (S\NP)\(S\NP) 	 2 	 did n't
23 	 21 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 trade did
26 	 25 	 NP[nb]/N 	 1 	 company the
26 	 27 	 (S[dcl]\NP)/NP 	 1 	 company forecast
27 	 1 	 S/S 	 1 	 forecast day
30 	 27 	 (S[dcl]\NP)/NP 	 2 	 drop forecast
30 	 28 	 NP[nb]/N 	 1 	 drop a
30 	 29 	 N/N 	 1 	 drop significant
30 	 32 	 NP\NP 	 1 	 drop year
30 	 33 	 (NP\NP)/NP 	 1 	 drop in
32 	 31 	 (NP\NP)/(NP\NP) 	 2 	 year next
34 	 33 	 (NP\NP)/NP 	 2 	 sales in
34 	 35 	 (NP\NP)/NP 	 1 	 sales of
38 	 35 	 (NP\NP)/NP 	 2 	 product of
38 	 36 	 NP[nb]/N 	 1 	 product its
38 	 37 	 N/N 	 1 	 product core
<\s>
<s id="wsj_0970.2"> 32
1 	 0 	 NP[nb]/N 	 1 	 disclosure That
1 	 2 	 S[dcl]\NP 	 1 	 disclosure came
2 	 9 	 ((S\NP)\(S\NP))/S[dcl] 	 2 	 came after
6 	 4 	 NP[nb]/N 	 1 	 spokeswoman a
6 	 5 	 N/N 	 1 	 spokeswoman Delmed
6 	 7 	 (S[dcl]\NP)/S[dcl] 	 1 	 spokeswoman said
13 	 10 	 NP[nb]/N 	 1 	 Exchange the
13 	 11 	 N/N 	 1 	 Exchange American
13 	 12 	 N/N 	 1 	 Exchange Stock
13 	 14 	 ((S[dcl]\NP)/S[em])/NP 	 1 	 Exchange alerted
14 	 9 	 ((S\NP)\(S\NP))/S[dcl] 	 3 	 alerted after
16 	 14 	 ((S[dcl]\NP)/S[em])/NP 	 3 	 company alerted
16 	 15 	 NP[nb]/N 	 1 	 company the
17 	 14 	 ((S[dcl]\NP)/S[em])/NP 	 2 	 that alerted
18 	 19 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 trading would
18 	 21 	 S[b]\NP 	 1 	 trading resume <XB>
19 	 17 	 S[em]/S[dcl] 	 1 	 would that
19 	 20 	 (S\NP)\(S\NP) 	 2 	 would n't
21 	 19 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 resume would
21 	 22 	 ((S\NP)\(S\NP))/NP 	 2 	 resume in
21 	 25 	 ((S\NP)\(S\NP))/S[dcl] 	 2 	 resume until
24 	 22 	 ((S\NP)\(S\NP))/NP 	 3 	 stock in
24 	 23 	 NP[nb]/N 	 1 	 stock its
27 	 26 	 N/N 	 1 	 information additional
27 	 28 	 (NP\NP)/NP 	 1 	 information about
27 	 30 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 information was
27 	 31 	 S[pss]\NP 	 1 	 information provided <XB>
29 	 28 	 (NP\NP)/NP 	 2 	 developments about
30 	 25 	 ((S\NP)\(S\NP))/S[dcl] 	 3 	 was until
31 	 30 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 provided was
<\s>
<s id="wsj_0970.3"> 20
1 	 0 	 (S/S)/NP 	 2 	 addition In
1 	 2 	 (NP\NP)/NP 	 1 	 addition to
4 	 2 	 (NP\NP)/NP 	 2 	 forecast to
4 	 3 	 NP[nb]/N 	 1 	 forecast the
7 	 6 	 NP[nb]/N 	 1 	 company the
7 	 9 	 (S[dcl]\NP)/S[dcl] 	 1 	 company said
9 	 0 	 (S/S)/NP 	 1 	 said In
9 	 8 	 (S\NP)/(S\NP) 	 2 	 said also
10 	 11 	 (S[dcl]\NP)/(S[ng]\NP) 	 1 	 it is
10 	 12 	 (S[ng]\NP)/NP 	 1 	 it examining <XB>
11 	 9 	 (S[dcl]\NP)/S[dcl] 	 2 	 is said
12 	 11 	 (S[dcl]\NP)/(S[ng]\NP) 	 2 	 examining is
15 	 12 	 (S[ng]\NP)/NP 	 2 	 cuts examining
15 	 13 	 N/N 	 1 	 cuts potential
15 	 14 	 N/N 	 1 	 cuts cost
17 	 12 	 (S[ng]\NP)/NP 	 2 	 reductions examining
17 	 18 	 (NP\NP)/NP 	 1 	 reductions in
19 	 18 	 (NP\NP)/NP 	 2 	 overhead in
<\s>
<s id="wsj_0970.4"> 12
1 	 0 	 NP[nb]/N 	 1 	 spokeswoman The
1 	 2 	 (S[dcl]\NP)/S[dcl] 	 1 	 spokeswoman said
4 	 3 	 NP[nb]/N 	 1 	 exchange the
4 	 5 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 exchange would
4 	 6 	 (S[b]\NP)/NP 	 1 	 exchange resume <XB>
5 	 2 	 (S[dcl]\NP)/S[dcl] 	 2 	 would said
6 	 5 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 resume would
6 	 11 	 (S\NP)\(S\NP) 	 2 	 resume today
7 	 6 	 (S[b]\NP)/NP 	 2 	 trading resume
7 	 8 	 (NP\NP)/NP 	 1 	 trading of
10 	 8 	 (NP\NP)/NP 	 2 	 stock of
10 	 9 	 N/N 	 1 	 stock Delmed
<\s>
<s id="wsj_0970.5"> 46
0 	 2 	 (NP\NP)/(S[dcl]\NP) 	 1 	 Delmed which
0 	 3 	 (S[dcl]\NP)/NP 	 1 	 Delmed makes <XB>
0 	 5 	 (S[dcl]\NP)/NP 	 1 	 Delmed sells <XU>
0 	 17 	 (S[dcl]\NP)/NP 	 1 	 Delmed announced
3 	 2 	 (NP\NP)/(S[dcl]\NP) 	 2 	 makes which
5 	 2 	 (NP\NP)/(S[dcl]\NP) 	 2 	 sells which
8 	 3 	 (S[dcl]\NP)/NP 	 2 	 products makes <XU>
8 	 5 	 (S[dcl]\NP)/NP 	 2 	 products sells
8 	 6 	 N/N 	 1 	 products peritoneal
8 	 7 	 N/N 	 1 	 products dialysis
8 	 9 	 S[pss]\NP 	 1 	 products used <XB>
8 	 11 	 (S[ng]\NP)/NP 	 1 	 products treating <XB>
9 	 10 	 ((S\NP)\(S\NP))/(S[ng]\NP) 	 2 	 used in
11 	 10 	 ((S\NP)\(S\NP))/(S[ng]\NP) 	 3 	 treating in
13 	 11 	 (S[ng]\NP)/NP 	 2 	 disease treating
13 	 12 	 N/N 	 1 	 disease kidney
16 	 15 	 ((S\NP)/(S\NP))/NP 	 3 	 Tuesday on
17 	 15 	 ((S\NP)/(S\NP))/NP 	 2 	 announced on
19 	 17 	 (S[dcl]\NP)/NP 	 2 	 resignations announced
19 	 18 	 NP[nb]/N 	 1 	 resignations the
19 	 20 	 (NP\NP)/NP 	 1 	 resignations of
19 	 34 	 (NP\NP)/NP 	 1 	 resignations of <XU>
23 	 20 	 (NP\NP)/NP 	 2 	 Ehrlich of
23 	 21 	 N/N 	 1 	 Ehrlich Robert
23 	 22 	 N/N 	 1 	 Ehrlich S.
25 	 20 	 (NP\NP)/NP 	 2 	 chairman of
27 	 20 	 (NP\NP)/NP 	 2 	 president of
31 	 20 	 (NP\NP)/NP 	 2 	 officer of
31 	 29 	 N/N 	 1 	 officer chief
31 	 30 	 N/N 	 1 	 officer executive
37 	 34 	 (NP\NP)/NP 	 2 	 Shapiro of
37 	 35 	 N/N 	 1 	 Shapiro Leslie
37 	 36 	 N/N 	 1 	 Shapiro I.
41 	 34 	 (NP\NP)/NP 	 2 	 officer of
41 	 39 	 N/N 	 1 	 officer chief
41 	 40 	 N/N 	 1 	 officer operating
45 	 34 	 (NP\NP)/NP 	 2 	 officer of
45 	 43 	 N/N 	 1 	 officer chief
45 	 44 	 N/N 	 1 	 officer financial
<\s>
<s id="wsj_0970.6"> 23
0 	 1 	 (S[dcl]\NP)/(S[pss]\NP) 	 1 	 They were
0 	 2 	 S[pss]\NP 	 1 	 They succeeded <XB>
2 	 1 	 (S[dcl]\NP)/(S[pss]\NP) 	 2 	 succeeded were
2 	 3 	 ((S\NP)\(S\NP))/NP 	 2 	 succeeded by
4 	 3 	 ((S\NP)\(S\NP))/NP 	 3 	 executives by
4 	 5 	 (NP\NP)/NP 	 1 	 executives of
8 	 5 	 (NP\NP)/NP 	 2 	 Inc. of
8 	 6 	 N/N 	 1 	 Inc. Fresenius
8 	 7 	 N/N 	 1 	 Inc. USA
11 	 5 	 (NP\NP)/NP 	 2 	 parent of
11 	 10 	 NP[nb]/N 	 1 	 parent its
11 	 16 	 (NP\NP)/(S[dcl]\NP) 	 1 	 parent which
11 	 17 	 (S[dcl]\NP)/NP 	 1 	 parent owns <XB>
14 	 5 	 (NP\NP)/NP 	 2 	 AG of
14 	 13 	 N/N 	 1 	 AG Fresenius
14 	 16 	 (NP\NP)/(S[dcl]\NP) 	 1 	 AG which
14 	 17 	 (S[dcl]\NP)/NP 	 1 	 AG owns <XB>
17 	 16 	 (NP\NP)/(S[dcl]\NP) 	 2 	 owns which
19 	 18 	 (N/N)/(N/N) 	 2 	 45 about
20 	 17 	 (S[dcl]\NP)/NP 	 2 	 % owns
20 	 19 	 N/N 	 1 	 % 45
20 	 21 	 (NP\NP)/NP 	 1 	 % of
22 	 21 	 (NP\NP)/NP 	 2 	 Delmed of
<\s>
<s id="wsj_0970.7"> 36
3 	 0 	 (S/S)/NP 	 2 	 time At
3 	 1 	 NP[nb]/N 	 1 	 time the
3 	 2 	 N/N 	 1 	 time same
9 	 6 	 (N/N)/(N/N) 	 2 	 N.J. New
9 	 7 	 (N/N)/(N/N) 	 2 	 N.J. Brunswick
11 	 5 	 NP[nb]/N 	 1 	 company the
11 	 9 	 N/N 	 1 	 company N.J.
11 	 12 	 (S[dcl]\NP)/S[dcl] 	 1 	 company said
12 	 0 	 (S/S)/NP 	 1 	 said At
13 	 14 	 (NP\NP)/NP 	 1 	 negotiations about
13 	 20 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 negotiations had
13 	 21 	 S[pt]\NP 	 1 	 negotiations collapsed <XB>
15 	 14 	 (NP\NP)/NP 	 2 	 pricing about
17 	 14 	 (NP\NP)/NP 	 2 	 volumes about
17 	 18 	 (NP\NP)/NP 	 1 	 volumes of
19 	 18 	 (NP\NP)/NP 	 2 	 product of
20 	 12 	 (S[dcl]\NP)/S[dcl] 	 2 	 had said
21 	 20 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 collapsed had
21 	 22 	 ((S\NP)\(S\NP))/NP 	 2 	 collapsed between
23 	 22 	 ((S\NP)\(S\NP))/NP 	 3 	 it between
27 	 22 	 ((S\NP)\(S\NP))/NP 	 3 	 distributor between
27 	 25 	 NP[nb]/N 	 1 	 distributor its
27 	 26 	 N/N 	 1 	 distributor exclusive
27 	 28 	 (NP\NP)/NP 	 1 	 distributor in
30 	 28 	 (NP\NP)/NP 	 2 	 U.S. in
30 	 29 	 NP[nb]/N 	 1 	 U.S. the
35 	 22 	 ((S\NP)\(S\NP))/NP 	 3 	 Inc between
35 	 32 	 N/N 	 1 	 Inc National
35 	 33 	 N/N 	 1 	 Inc Medical
35 	 34 	 N/N 	 1 	 Inc Care
<\s>
<s id="wsj_0970.8"> 13
3 	 0 	 (S/S)/NP 	 2 	 Tuesday Following
3 	 1 	 NP[nb]/N 	 1 	 Tuesday that
3 	 2 	 N/N 	 1 	 Tuesday announcement
8 	 7 	 N/N 	 1 	 officials company
8 	 9 	 (S[dcl]\NP)/(S[adj]\NP) 	 1 	 officials were
8 	 10 	 (S[adj]\NP)/(S[to]\NP) 	 1 	 officials unavailable <XB>
9 	 0 	 (S/S)/NP 	 1 	 were Following
9 	 5 	 S/S 	 1 	 were however
10 	 9 	 (S[dcl]\NP)/(S[adj]\NP) 	 2 	 unavailable were
11 	 10 	 (S[adj]\NP)/(S[to]\NP) 	 2 	 to unavailable
12 	 11 	 (S[to]\NP)/(S[b]\NP) 	 2 	 elaborate to
<\s>
<s id="wsj_0970.9"> 29
3 	 2 	 NP[nb]/N 	 1 	 spokeswoman the
3 	 4 	 (S[dcl]\NP)/S[dcl] 	 1 	 spokeswoman said
4 	 0 	 S/S 	 1 	 said Yesterday
5 	 6 	 (NP\NP)/NP 	 1 	 sales of
5 	 9 	 (NP\NP)/NP 	 1 	 sales through
5 	 16 	 (S[dcl]\NP)/PP 	 1 	 sales accounted
8 	 6 	 (NP\NP)/NP 	 2 	 products of
8 	 7 	 N/N 	 1 	 products Delmed
12 	 9 	 (NP\NP)/NP 	 2 	 arrangement through
12 	 10 	 NP[nb]/N 	 1 	 arrangement the
12 	 11 	 N/N 	 1 	 arrangement exclusive
12 	 13 	 (NP\NP)/NP 	 1 	 arrangement with
15 	 13 	 (NP\NP)/NP 	 2 	 Medical with
15 	 14 	 N/N 	 1 	 Medical National
16 	 4 	 (S[dcl]\NP)/S[dcl] 	 2 	 accounted said
17 	 16 	 (S[dcl]\NP)/PP 	 2 	 for accounted
19 	 17 	 PP/NP 	 1 	 % for
19 	 18 	 N/N 	 1 	 % 87
19 	 20 	 (NP\NP)/NP 	 1 	 % of
21 	 22 	 (NP[nb]/N)\NP 	 2 	 Delmed 's
24 	 20 	 (NP\NP)/NP 	 2 	 sales of
24 	 22 	 (NP[nb]/N)\NP 	 1 	 sales 's
24 	 23 	 N/N 	 1 	 sales 1988
24 	 25 	 (NP\NP)/NP 	 1 	 sales of
26 	 25 	 (NP\NP)/NP 	 2 	 $ of
28 	 26 	 N/N[num] 	 1 	 million $
28 	 27 	 N/N 	 1 	 million 21.1
<\s>
<s id="wsj_0970.10"> 31
3 	 0 	 NP[nb]/N 	 1 	 arrangement The
3 	 1 	 N/N 	 1 	 arrangement current
3 	 2 	 N/N 	 1 	 arrangement distribution
3 	 4 	 S[dcl]\NP 	 1 	 arrangement ends
4 	 5 	 ((S\NP)\(S\NP))/NP 	 2 	 ends in
4 	 9 	 ((S\NP)\(S\NP))/S[dcl] 	 2 	 ends although
4 	 30 	 (S[dcl]\S[dcl])\NP 	 1 	 ends said
6 	 5 	 ((S\NP)\(S\NP))/NP 	 3 	 March in
6 	 7 	 N\N 	 1 	 March 1990
10 	 11 	 (S[dcl]\NP)/S[dcl] 	 1 	 Delmed said
11 	 9 	 ((S\NP)\(S\NP))/S[dcl] 	 3 	 said although
12 	 13 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 it will
12 	 14 	 (S[b]\NP)/(S[to]\NP) 	 1 	 it continue <XB>
12 	 16 	 ((S[b]\NP)/PP)/NP 	 1 	 it provide <XB>
13 	 11 	 (S[dcl]\NP)/S[dcl] 	 2 	 will said
14 	 13 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 continue will
15 	 14 	 (S[b]\NP)/(S[to]\NP) 	 2 	 to continue
16 	 15 	 (S[to]\NP)/(S[b]\NP) 	 2 	 provide to
18 	 16 	 ((S[b]\NP)/PP)/NP 	 3 	 supplies provide
18 	 17 	 NP[nb]/N 	 1 	 supplies some
18 	 19 	 (NP\NP)/NP 	 1 	 supplies of
23 	 19 	 (NP\NP)/NP 	 2 	 products of
23 	 20 	 NP[nb]/N 	 1 	 products the
23 	 21 	 N/N 	 1 	 products peritoneal
23 	 22 	 N/N 	 1 	 products dialysis
24 	 16 	 ((S[b]\NP)/PP)/NP 	 2 	 to provide
26 	 24 	 PP/NP 	 1 	 Medical to
26 	 25 	 N/N 	 1 	 Medical National
29 	 28 	 NP[nb]/N 	 1 	 spokeswoman the
29 	 30 	 (S[dcl]\S[dcl])\NP 	 2 	 spokeswoman said
<\s>
<s id="wsj_0970.11"> 23
2 	 4 	 (S[dcl]\NP)/S[em] 	 1 	 Delmed expects
4 	 0 	 S/S 	 1 	 expects Nonetheless
4 	 3 	 (S\NP)/(S\NP) 	 2 	 expects currently
4 	 19 	 (S[dcl]\S[dcl])\NP 	 1 	 expects said
5 	 4 	 (S[dcl]\NP)/S[em] 	 2 	 that expects
7 	 6 	 N/N 	 1 	 sales 1990
7 	 9 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 sales will
7 	 10 	 (S[b]\NP)/PP 	 1 	 sales be <XB>
9 	 5 	 S[em]/S[dcl] 	 1 	 will that
10 	 9 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 be will
12 	 10 	 (S[b]\NP)/PP 	 2 	 below be
12 	 11 	 PP/PP 	 1 	 below significantly
15 	 12 	 PP/NP 	 1 	 level below
15 	 13 	 NP[nb]/N 	 1 	 level their
15 	 14 	 N/N 	 1 	 level 1989
18 	 17 	 NP[nb]/N 	 1 	 company the
18 	 19 	 (S[dcl]\S[dcl])\NP 	 2 	 company said
19 	 20 	 (S\S)/NP 	 1 	 said in
22 	 20 	 (S\S)/NP 	 2 	 statement in
22 	 21 	 NP[nb]/N 	 1 	 statement a
<\s>
<s id="wsj_0970.12"> 21
0 	 1 	 (S[dcl]\NP)/S[em] 	 1 	 Delmed said
1 	 2 	 (S\NP)\(S\NP) 	 2 	 said yesterday
3 	 1 	 (S[dcl]\NP)/S[em] 	 2 	 that said
5 	 4 	 N/N 	 1 	 USA Fresenius
5 	 6 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 USA would
5 	 7 	 (S[b]\NP)/(S[ng]\NP) 	 1 	 USA begin <XB>
5 	 8 	 (S[ng]\NP)/NP 	 1 	 USA distributing <XB>
6 	 3 	 S[em]/S[dcl] 	 1 	 would that
7 	 6 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 begin would
8 	 7 	 (S[b]\NP)/(S[ng]\NP) 	 2 	 distributing begin
10 	 8 	 (S[ng]\NP)/NP 	 2 	 product distributing
10 	 9 	 NP[nb]/N 	 1 	 product the
12 	 1 	 (S[dcl]\NP)/S[em] 	 2 	 that said
14 	 13 	 NP[nb]/N 	 1 	 company the
14 	 15 	 (S[dcl]\NP)/(S[ng]\NP) 	 1 	 company is
14 	 16 	 (S[ng]\NP)/NP 	 1 	 company investigating <XB>
15 	 12 	 S[em]/S[dcl] 	 1 	 is that
16 	 15 	 (S[dcl]\NP)/(S[ng]\NP) 	 2 	 investigating is
20 	 16 	 (S[ng]\NP)/NP 	 2 	 channels investigating
20 	 17 	 N/N 	 1 	 channels other
20 	 18 	 N/N 	 1 	 channels possible
20 	 19 	 N/N 	 1 	 channels distribution
<\s>
<s id="wsj_0970.13"> 15
2 	 0 	 (S/S)/NP 	 2 	 case In
2 	 1 	 NP[nb]/N 	 1 	 case any
4 	 5 	 (NP\NP)/NP 	 1 	 supplies to
4 	 7 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 supplies wo
4 	 10 	 S[pss]\NP 	 1 	 supplies interrupted <XB>
6 	 5 	 (NP\NP)/NP 	 2 	 patients to
7 	 0 	 (S/S)/NP 	 1 	 wo In
7 	 8 	 (S\NP)\(S\NP) 	 2 	 wo n't
7 	 14 	 (S[dcl]\S[dcl])\NP 	 1 	 wo added
9 	 7 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 be wo
10 	 9 	 (S[b]\NP)/(S[pss]\NP) 	 2 	 interrupted be
13 	 12 	 NP[nb]/N 	 1 	 company the
13 	 14 	 (S[dcl]\S[dcl])\NP 	 2 	 company added
<\s>
<s id="wsj_0970.14"> 34
0 	 8 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 Fresenius has
0 	 10 	 (S[ng]\NP)/NP 	 1 	 Fresenius discussing <XB>
4 	 3 	 (N/N)/(N/N) 	 2 	 German West
6 	 2 	 NP[nb]/N 	 1 	 concern a
6 	 4 	 N/N 	 1 	 concern German
6 	 5 	 N/N 	 1 	 concern pharmaceutical
6 	 8 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 concern has
6 	 10 	 (S[ng]\NP)/NP 	 1 	 concern discussing <XB>
9 	 8 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 been has
10 	 9 	 (S[pt]\NP)/(S[ng]\NP) 	 2 	 discussing been
12 	 10 	 (S[ng]\NP)/NP 	 2 	 transaction discussing
12 	 11 	 NP[nb]/N 	 1 	 transaction a
12 	 14 	 ((NP\NP)/S[dcl])\((NP\NP)/NP) 	 1 	 transaction which
13 	 14 	 ((NP\NP)/S[dcl])\((NP\NP)/NP) 	 3 	 in which
15 	 16 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 it would
15 	 17 	 ((S[b]\NP)/PP)/NP 	 1 	 it buy <XB>
15 	 23 	 (S[b]\NP)/NP 	 1 	 it bring <XB>
16 	 14 	 ((NP\NP)/S[dcl])\((NP\NP)/NP) 	 2 	 would which
17 	 16 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 buy would
19 	 17 	 ((S[b]\NP)/PP)/NP 	 3 	 stock buy
19 	 18 	 N/N 	 1 	 stock Delmed
20 	 17 	 ((S[b]\NP)/PP)/NP 	 2 	 for buy
21 	 20 	 PP/NP 	 1 	 cash for
23 	 22 	 (S[to]\NP)/(S[b]\NP) 	 2 	 bring to
23 	 27 	 ((S\NP)\(S\NP))/NP 	 2 	 bring to
26 	 23 	 (S[b]\NP)/NP 	 2 	 ownership bring
26 	 24 	 NP[nb]/N 	 1 	 ownership its
26 	 25 	 N/N 	 1 	 ownership beneficial
30 	 27 	 ((S\NP)\(S\NP))/NP 	 3 	 % to
30 	 28 	 N/N 	 1 	 % between
30 	 29 	 N/N 	 1 	 % 70
33 	 27 	 ((S\NP)\(S\NP))/NP 	 3 	 % to
33 	 28 	 N/N 	 1 	 % between
33 	 32 	 N/N 	 1 	 % 80
<\s>
<s id="wsj_0970.15"> 9
1 	 0 	 NP[nb]/N 	 1 	 transaction The
1 	 3 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 transaction would
1 	 4 	 (S[b]\NP)/NP 	 1 	 transaction combine <XB>
3 	 2 	 (S\NP)/(S\NP) 	 2 	 would also
4 	 3 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 combine would
6 	 4 	 (S[b]\NP)/NP 	 2 	 USA combine
6 	 5 	 N/N 	 1 	 USA Fresenius
8 	 4 	 (S[b]\NP)/NP 	 2 	 Delmed combine
<\s>
<s id="wsj_0970.16"> 22
2 	 1 	 NP[nb]/N 	 1 	 plan the
2 	 4 	 (S[dcl]\NP)/(S[ng]\NP) 	 1 	 plan is
2 	 5 	 (S[ng]\NP)/(S[pss]\NP) 	 1 	 plan being <XB>
2 	 6 	 S[pss]\NP 	 1 	 plan reformulated <XB>
4 	 0 	 S/S 	 1 	 is But
4 	 3 	 (S\NP)/(S\NP) 	 2 	 is now
4 	 9 	 (S[dcl]\S[dcl])\NP 	 1 	 is said
5 	 4 	 (S[dcl]\NP)/(S[ng]\NP) 	 2 	 being is
6 	 5 	 (S[ng]\NP)/(S[pss]\NP) 	 2 	 reformulated being
8 	 9 	 (S[dcl]\S[dcl])\NP 	 2 	 Delmed said
12 	 11 	 (S[ng]\NP)/(S[to]\NP) 	 2 	 to declining
13 	 12 	 (S[to]\NP)/(S[b]\NP) 	 2 	 provide to
14 	 13 	 (S[b]\NP)/NP 	 2 	 most provide
14 	 15 	 (NP\NP)/NP 	 1 	 most of
18 	 15 	 (NP\NP)/NP 	 2 	 terms of
18 	 16 	 NP[nb]/N 	 1 	 terms the
18 	 17 	 N/N 	 1 	 terms new
18 	 19 	 (NP\NP)/NP 	 1 	 terms of
21 	 19 	 (NP\NP)/NP 	 2 	 combination of
21 	 20 	 NP[nb]/N 	 1 	 combination the
<\s>
<s id="wsj_0970.17"> 9
2 	 0 	 (S[dcl]/S[dcl])/NP 	 2 	 spokeswoman Said
2 	 1 	 NP[nb]/N 	 1 	 spokeswoman the
6 	 4 	 NP[nb]/N 	 1 	 structure The
6 	 5 	 N/N 	 1 	 structure whole
6 	 7 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 structure has
6 	 8 	 S[pt]\NP 	 1 	 structure changed <XB>
7 	 0 	 (S[dcl]/S[dcl])/NP 	 1 	 has Said
8 	 7 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 changed has
<\s>
<s id="wsj_0970.18"> 7
1 	 0 	 NP[nb]/N 	 1 	 value The
1 	 2 	 (NP\NP)/NP 	 1 	 value of
1 	 5 	 (S[dcl]\NP)/(S[pt]\NP) 	 1 	 value has
1 	 6 	 S[pt]\NP 	 1 	 value changed <XB>
4 	 2 	 (NP\NP)/NP 	 2 	 company of
4 	 3 	 NP[nb]/N 	 1 	 company the
6 	 5 	 (S[dcl]\NP)/(S[pt]\NP) 	 2 	 changed has
<\s>
<s id="wsj_0970.19"> 21
0 	 1 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 Delmed did
0 	 2 	 (S[b]\NP)/S[em] 	 1 	 Delmed say <XB>
2 	 1 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 say did
3 	 2 	 (S[b]\NP)/S[em] 	 2 	 that say
5 	 4 	 NP[nb]/N 	 1 	 proposal the
5 	 7 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 proposal would
5 	 8 	 ((S[b]\NP)/PP)/NP 	 1 	 proposal infuse <XB>
7 	 3 	 S[em]/S[dcl] 	 1 	 would that
7 	 6 	 (S\NP)/(S\NP) 	 2 	 would still
8 	 7 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 infuse would
8 	 13 	 (S\NP)\(S\NP) 	 2 	 infuse less
9 	 8 	 ((S[b]\NP)/PP)/NP 	 3 	 cash infuse
10 	 8 	 ((S[b]\NP)/PP)/NP 	 2 	 into infuse
11 	 10 	 PP/NP 	 1 	 Delmed into
13 	 12 	 ((S\NP)\(S\NP))/((S\NP)\(S\NP)) 	 3 	 less but
13 	 14 	 (((S\NP)\(S\NP))\((S\NP)\(S\NP)))/NP 	 3 	 less than
16 	 14 	 (((S\NP)\(S\NP))\((S\NP)\(S\NP)))/NP 	 4 	 $ than
16 	 15 	 NP[nb]/N 	 1 	 $ the
16 	 20 	 S[pss]\NP 	 1 	 $ expected <XB>
18 	 16 	 N/N[num] 	 1 	 million $
18 	 17 	 N/N 	 1 	 million 10
20 	 19 	 (S\NP)/(S\NP) 	 2 	 expected originally
<\s>
<s id="wsj_0970.20"> 13
0 	 2 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 Delmed would
0 	 3 	 (S[b]\NP)/NP 	 1 	 Delmed receive <XB>
2 	 1 	 (S\NP)/(S\NP) 	 2 	 would also
3 	 2 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 receive would
7 	 3 	 (S[b]\NP)/NP 	 2 	 rights receive
7 	 4 	 NP[nb]/N 	 1 	 rights the
7 	 5 	 N/N 	 1 	 rights North
7 	 6 	 N/N 	 1 	 rights American
7 	 8 	 (NP\NP)/NP 	 1 	 rights to
12 	 8 	 (NP\NP)/NP 	 2 	 products to
12 	 9 	 N/N 	 1 	 products certain
12 	 10 	 N/N 	 1 	 products Fresenius
12 	 11 	 N/N 	 1 	 products AG
<\s>
<s id="wsj_0970.21"> 20
1 	 0 	 NP[nb]/N 	 1 	 option Another
1 	 2 	 (NP\NP)/NP 	 1 	 option for
1 	 9 	 (S[dcl]\NP)/S[em] 	 1 	 option is
3 	 2 	 (NP\NP)/NP 	 2 	 Delmed for
6 	 5 	 NP[nb]/N 	 1 	 company the
6 	 7 	 (S[dcl]\NP)/S[dcl] 	 1 	 company said
10 	 9 	 (S[dcl]\NP)/S[em] 	 2 	 that is
11 	 12 	 (S[dcl]\NP)/(S[b]\NP) 	 1 	 it could
11 	 13 	 (S[b]\NP)/NP 	 1 	 it sell <XB>
12 	 10 	 S[em]/S[dcl] 	 1 	 could that
13 	 12 	 (S[dcl]\NP)/(S[b]\NP) 	 2 	 sell could
15 	 13 	 (S[b]\NP)/NP 	 2 	 plant sell
15 	 14 	 NP[nb]/N 	 1 	 plant its
15 	 16 	 (NP\NP)/NP 	 1 	 plant in
17 	 16 	 (NP\NP)/NP 	 2 	 Ogden in
19 	 16 	 (NP\NP)/NP 	 2 	 Utah in
<\s>
<s id="wsj_0970.22"> 12
0 	 1 	 (S[dcl]\NP)/S[em] 	 1 	 It added
2 	 1 	 (S[dcl]\NP)/S[em] 	 2 	 that added
4 	 3 	 NP[nb]/N 	 1 	 discussions no
4 	 5 	 (NP\NP)/NP 	 1 	 discussions about
4 	 9 	 (S[dcl]\NP)/PP 	 1 	 discussions are
8 	 5 	 (NP\NP)/NP 	 2 	 sale about
8 	 6 	 NP/NP 	 1 	 sale such
8 	 7 	 NP[nb]/N 	 1 	 sale a
9 	 2 	 S[em]/S[dcl] 	 1 	 are that
10 	 9 	 (S[dcl]\NP)/PP 	 2 	 under are
11 	 10 	 PP/NP 	 1 	 way under
<\s>
